Long-term outcome, mortality predictors and cardiac-device related infective endocarditis in patients with surgically corrected valvular versus non-valvular heart failure treated with cardiac resynchronization therapy
CRT recipients with valvular HF that had been corrected surgically have similar long-term mortality to CRT patients with non-valvular HF etiologies. In both, death rates reach 50% within 4.5 years. The risk of CDRIE is not higher in the valvular versus non-valvular group of CRT recipients, and advanced age appeared to be the only independent mortality predictor in patients with CRT implanted for valvular HF.
Authors
- Oskar Kowalski (ORCID: https://orcid.org/0000-0002-9421-9278)
- Jakub Gumprecht (ORCID: https://orcid.org/0000-0002-0575-9150)
- Patrycja Pruszkowska‐Skrzep
- Agnieszka Kotalczyk (ORCID: https://orcid.org/0000-0002-6762-3187)
- Michał Mazurek
- Wiktoria Kowalska (ORCID: https://orcid.org/0000-0001-5064-8217)
- Radosław Lenarczyk (ORCID: https://orcid.org/0000-0002-4680-6734)
- Zbigniew F. Kalarus (ORCID: https://orcid.org/0000-0003-3921-7234)
- Ewa Jędrzejczyk‐Patej (ORCID: https://orcid.org/0000-0002-1009-0076)
- Adam Sokal (ORCID: https://orcid.org/0000-0002-7302-9141)
- Jacek Kowalczyk
Institutions
- Medical University of Silesia (PL)
- Silesian Center for Heart Disease (PL)
Publication Details
- Journal
- Kardiologia Polska
- Published
- 2024-11-13
- DOI
- https://doi.org/10.33963/v.phj.103421
- Primary Topic
- Cardiac pacing and defibrillation studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company
- Pfizer
- European Commission